Olmesartan/Amlodipine Clonmel (Amlodipine, Olmesartan)

Amlodipine, the active ingredient in Olmesartan/Amlodipine Clonmel, is a calcium‑channel blocker presented as a combination tablet for oral use. It treats hypertension, often in combination with other antihypertensive agents, and is suitable for adult patients. GNH USA supplies Olmesartan/Amlodipine Clonmel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan/Amlodipine Clonmel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan/Amlodipine is used in the management of high blood pressure, acting on the renin‑angiotensin system and vascular smooth‑muscle tone. - Hypertension: Provides additive blood‑pressure reduction when used as initial therapy or in combination with other agents. - Hypertension with cardiovascular risk: Lowers systolic and diastolic pressures to reduce risk of stroke and myocardial infarction. - Hypertension resistant to monotherapy: Offers an alternative when single‑drug therapy does not achieve target blood pressure.

Adverse reactions may occur with any antihypertensive regimen and should be monitored during therapy.

Common Side Effects: - Peripheral edema: mild swelling of the ankles or feet. - Headache: transient tension‑type headache. - Dizziness: especially upon standing quickly. - Flushing: warm sensation with facial redness. - Fatigue: generalized tiredness. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Angio‑edema: rapid swelling of lips, tongue or airway. - Severe hypotension: symptomatic low blood pressure. - Hepatic dysfunction: abnormal liver enzymes. - Acute kidney injury: sudden decline in renal function.

Before initiating therapy, consider patient‑specific factors and monitor appropriately. - Renal impairment: adjust dose and monitor creatinine. - Hepatic impairment: use with caution; monitor liver function. - Pregnancy: contraindicated; avoid use in women of childbearing potential. - Concomitant diuretics: may increase risk of electrolyte imbalance. - Elderly patients: start at lower dose and titrate slowly. - Store at below 25°C: keep in the original packaging, protect from moisture.

Olmesartan/amlodipine may interact with several drug classes; clinical judgement is required.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyper‑kalemia. - Aliskiren (in diabetes): increased renal risk. - NSAIDs: may blunt antihypertensive effect and affect kidney function.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., itraconazole): increase amlod3 - CYP3A4 inducers:   -  ");